People Biography

السيرة الذاتية

Dr. Julia Reichelt qualified as a Molecular Biologist at Marburg University, Germany. She studied the biology of skin keratins at the Universities of Bonn and Cologne, Germany. At Newcastle University, UK, she started using genome editing technologies to develop gene therapies for keratinopathies including epidermolytic ichthyosis and epidermolysis bullosa. At EB House Austria, Salzburg, she was involved in the life-saving gene therapy in a boy with junctional epidermolysis bullosa who had 80% of his skin replaced with his own gene corrected keratinocytes. She continued to work on CRISPR-mediated gene therapy development in Innsbruck, Austria, before recently moving to Qatar to join Hamad Medical Corporation where her research is focused on translation of personalized gene therapy approaches into the clinic. Since 2022, she is affiliated with HBKU serving as Adjunct Associate Professor at the CHLS.

Dr. Julia supervised and mentored >50 students in her laboratory, published ˃ 55 peer reviewed articles, and has served as peer reviewer for several scientific journals and funding bodies.